Head-to-head · Value Score
bmiMD vs Breeze Meds
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Breeze Meds a 78. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameBreeze Meds
#34 · Grade B- · Fair Price
Est. first month
$199/mo
Save ~85% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 78 — an est. $99/mo first month, with no teaser step-up baked in. Breeze Meds isn't out of it: Shoppers who want a no-risk start and will ask what their actual dose costs before committing.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Breeze Meds |
|---|---|---|
| Value Score | 89 (A) | 78 (B-) |
| Est. first month | $99/mo | $199/mo |
| Save vs brand-name | ~93% | ~85% |
| Semaglutide | $99/mo | From $199/mo |
| Tirzepatide | $139/mo | From $299/mo first month, $399/mo thereafter |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Breeze Meds
Nationwide and charges nothing until you are approved, but its quoted prices are floors rather than what a working dose costs.
Why it's a deal
- Nothing charged until a provider approves you, and the consult is free if you go ahead
- One inclusive price covering consult, medication, supplies, shipping and support
- LegitScript certified, all 50 states, cancel or change plan at any time
The fine print
- Every figure quoted is for the LOWEST dose — the funnel says higher doses may cost more
- The $299 tirzepatide is a first-month rate; month-to-month is $399
- No molecule is named behind the public "from $199" — pricing only appears inside the intake
- An $80 consultation fee applies if you are approved and then decline
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.